HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shingo Harita Selected Research

Shingo Harita Research Topics

Disease

25Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021 - 07/2004
12Lung Neoplasms (Lung Cancer)
02/2021 - 01/2005
6Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2016 - 05/2002
5Neoplasms (Cancer)
01/2021 - 01/2010
2Diarrhea
12/2018 - 01/2016
2Disease Progression
11/2016 - 01/2010
2Disseminated Intravascular Coagulation
12/2015 - 11/2012
2Stomach Neoplasms (Stomach Cancer)
12/2015 - 11/2012
2Carcinoma (Carcinomatosis)
12/2015 - 12/2002
2Neoplasm Metastasis (Metastasis)
11/2012 - 02/2005
2Pulmonary Fibrosis (Fibrosing Alveolitis)
02/2010 - 09/2005
2Interstitial Lung Diseases (Interstitial Lung Disease)
02/2010 - 09/2005
2Neutropenia
08/2006 - 07/2004
1Dysbiosis
01/2021
1Hypokalemia
12/2018
1Esophagitis
01/2017
1Gastritis
01/2017
1Exanthema (Rash)
01/2016
1Mucositis
01/2016
1Thrombocytopenia (Thrombopenia)
08/2006
1Febrile Neutropenia
08/2006
1Hamman-Rich Syndrome (Hamman Rich Syndrome)
09/2005
1Thoracic Diseases
02/2005
1Brain Diseases (Brain Disorder)
02/2005
1Brain Neoplasms (Brain Tumor)
02/2005
1Pleural Effusion (Pleural Effusions)
12/2002
1Tuberculosis (Tuberculoses)
12/2002
1Pneumonia (Pneumonitis)
12/2002
1Heart Failure
12/2002

Drug/Important Bio-Agent (IBA)

8Cisplatin (Platino)FDA LinkGeneric
10/2016 - 03/2006
7ErbB Receptors (EGF Receptor)IBA
01/2021 - 01/2010
6Gefitinib (Iressa)FDA Link
01/2016 - 01/2005
5Immune Checkpoint InhibitorsIBA
11/2021 - 01/2021
5Tyrosine Kinase InhibitorsIBA
12/2018 - 01/2010
5Docetaxel (Taxotere)FDA Link
11/2012 - 07/2004
4Topotecan (Hycamtin)FDA LinkGeneric
10/2016 - 06/2006
3AfatinibIBA
12/2018 - 01/2016
3Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2016 - 01/2010
3amrubicinIBA
10/2011 - 05/2005
3Irinotecan (Camptosar)FDA LinkGeneric
06/2007 - 07/2004
2Anti-Bacterial Agents (Antibiotics)IBA
11/2021 - 01/2021
2Anaplastic Lymphoma KinaseIBA
01/2019 - 11/2016
2PlatinumIBA
01/2017 - 07/2004
2Dacarbazine (DIC)FDA LinkGeneric
12/2015 - 11/2012
2GemcitabineFDA Link
06/2007 - 03/2006
2Etoposide (VP 16)FDA LinkGeneric
06/2007 - 05/2002
1B7-H1 AntigenIBA
02/2021
1Programmed Cell Death 1 ReceptorIBA
02/2021
1Pharmaceutical PreparationsIBA
01/2019
1Cytotoxins (Cytolysins)IBA
12/2018
1CreatinineIBA
12/2018
1AlginatesIBA
01/2017
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
11/2016
1alectinibIBA
11/2016
1CrizotinibIBA
11/2016
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
11/2016
1Therapeutic UsesIBA
01/2016
1Monoclonal AntibodiesIBA
12/2015
1Trastuzumab (Herceptin)FDA Link
12/2015
1human ERBB2 proteinIBA
12/2015
1Fluorouracil (Carac)FDA LinkGeneric
01/2011
1Vindesine (Vindesin)IBA
07/2010
1Mitomycin (Mitomycin-C)FDA LinkGeneric
07/2010
1Biomarkers (Surrogate Marker)IBA
01/2010
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2007
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2007
1Vinorelbine (Navelbine)FDA LinkGeneric
02/2005
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
07/2004
1Collagen Type III (Type III Collagen)IBA
12/2002
1Interleukin-2 Receptors (IL 2 Receptor)IBA
12/2002
1Carboplatin (JM8)FDA LinkGeneric
05/2002

Therapy/Procedure

11Drug Therapy (Chemotherapy)
12/2018 - 02/2005
9Therapeutics
02/2021 - 02/2005
8Radiotherapy
08/2021 - 02/2005
5Combination Drug Therapy (Combination Chemotherapy)
11/2012 - 05/2002
2Chemoradiotherapy
01/2017 - 02/2005